95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.25%
Revenue growth similar to FNV's 14.32%. Walter Schloss would see if both companies share industry tailwinds.
29.46%
Gross profit growth similar to FNV's 30.64%. Walter Schloss would assume both firms track common industry trends.
37.40%
EBIT growth similar to FNV's 38.07%. Walter Schloss might infer both firms share similar operational efficiencies.
37.40%
Operating income growth similar to FNV's 34.62%. Walter Schloss would assume both share comparable operational structures.
47.16%
Net income growth 1.25-1.5x FNV's 41.00%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
40.00%
EPS growth 1.25-1.5x FNV's 33.33%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
40.00%
Diluted EPS growth 1.25-1.5x FNV's 33.33%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
8.38%
Share count expansion well above FNV's 6.59%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
8.40%
Diluted share count expanding well above FNV's 7.11%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
18.03%
Positive OCF growth while FNV is negative. John Neff would see this as a clear operational advantage vs. the competitor.
16.51%
FCF growth under 50% of FNV's 110.08%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
122.35%
10Y revenue/share CAGR 1.25-1.5x FNV's 107.69%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
-11.80%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
3.37%
3Y revenue/share CAGR under 50% of FNV's 33.54%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
103.41%
10Y OCF/share CAGR above 1.5x FNV's 60.52%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-35.46%
Negative 5Y OCF/share CAGR while FNV is at 14.89%. Joel Greenblatt would question the firm’s operational model or cost structure.
-12.92%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
19.00%
Below 50% of FNV's 141.62%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-67.05%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-31.11%
Negative 3Y CAGR while FNV is 61.69%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
304.82%
10Y equity/share CAGR above 1.5x FNV's 52.60%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
59.92%
5Y equity/share CAGR above 1.5x FNV's 14.72%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
22.20%
3Y equity/share CAGR above 1.5x FNV's 11.82%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
180.39%
5Y dividend/share CAGR above 1.5x FNV's 105.10%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
-67.63%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
156.53%
AR growth well above FNV's 13.03%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-0.03%
Negative asset growth while FNV invests at 0.69%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
7.42%
Positive BV/share change while FNV is negative. John Neff sees a clear edge over a competitor losing equity.
-48.50%
We’re deleveraging while FNV stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-4.25%
We cut SG&A while FNV invests at 5.56%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.